CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Management of No-Reflow Phenomenon in the Catheterization Laboratory Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease A Special Report From the American Heart Association and American College of Cardiolog Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study

ConsensusMarch 27, 2020

JOURNAL:Circulation. Article Link

CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic

YL Han , HS Zeng , H Jiang et al. Keywords: COVID-19; consensus ; severe emergent cardiovascular diseases

FULL TEXT PDF